ADDF-Harrington Scholar Program

How to Apply: 

The Alzheimer’s Drug Discovery Foundation (ADDF) and Harrington Discovery Institute have partnered to form the ADDF-Harrington Scholar program. The program recognizes physicians or scientists across the US, Canada and the United Kingdom, who are doing research to develop drugs to prevent, treat and cure Alzheimer’s disease. The award provides funding and drug development support to help bridge the gap between basic discovery and the clinical realm.

Program Description

Up to 3 ADDF-Harrington Scholars are chosen each year. The award includes:

  • Funding up to $600,000 over two years
  • Drug development expertise and project management support through the Harrington Discovery Institute Therapeutics Development Team
  • Consulting services from highly experienced drug development personnel
  • Business and commercialization advice
  • Clinical development advice
  • Regulatory assistance
  • Intellectual property review and advice
  • Assistance identifying and securing additional financial support based on project needs

The Harrington Discovery Institute and its Therapeutics Development team will work closely with the awardee and their affiliated institution to maximize the clinical and commercial potential of the selected project.

What We Fund

The ADDF-Harrington Scholar Award selection committee seeks breakthrough discovery defined by innovation, creativity and potential clinical impact, including:

  • Discoveries deemed to address unmet medical needs
  • Modulators of novel targets
  • Potential to be developed into a commercial program
  • Possess strong intellectual property (IP) or protection strategy
  • May be either a small molecule, biologic, or other therapeutic modality
  • Diagnostics or devices only acceptable as part of a therapeutic development project or if completely transformative
External Deadline: 
Friday, April 23, 2021
Funding Source: 
Funding Level: